glp 1 agonist medications New GLP-1 Guidelines for Type 2 Diabetes in 2025 GLP-1 Agonists - What is

GLP-1 receptor signaling in pancreatic alpha cells reduces glucagon secretion, further contributing to glucose lowering

Perioperative use of glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter 2 inhibitors for diabetes mellitus

Understanding these GLP-1 benefits helps patients make informed healthcare decisions

Double power: CagriSema Novo Nordisks CagriSema builds on the success of semaglutide by combining it with an amylin analogue (amylin helps manage blood sugar)

The primary benefit of a living guideline is that recommendations can be updated as new data becomes available

doi: 10.1111/dom.13206